Influence of n-3 Fish Oil-Enriched Intravenous Lipid Emulsion on Length of Stay and Mortality in Infants Post Intestinal Surgery

Meta Herdiana Hanindita, Khadijah Rizky Sumitro, Nur Aisiyah Widjaja, Roedi Irawan, Boerhan Hidayat

Abstract


Background: Parenteral nutrition plays an important role in the infants post intestinal surgery. Currently, n-6 soybean oil-based intravenous lipid emulsion (IVLE) is used as a standard. n-6 have been shown increases biomarkers of inflammation while n-3 have shown positively influence clinical outcomes due to their immunomodulatory action. The aim of this study is to investigate the influence of n-3 fish oil-enriched IVLE on mortality and length of stay in infants post intestinal surgery. Methods: A medical record retrospective study was undertaken in infants post intestinal surgery at Dr. Soetomo Hospital in 2016-2017. Infants with intestinal atresia who had PN for at least three days were included. The n-6 soybean oil-based and n-3 fish oil-enriched IVLE were used. Incomplete data was excluded. Results: There were 19 infants (12/19 boys) included in this study. 10/19 infants received the n-6 soybean oil-based IVLE. The duration and dose of IVLE used were 16.52±11.34 days and 1.80±0.44 g/kg/day. Mortality rate was significantly lower in n-3 fish oil-enriched IVLE group (P=0.02) while there was no difference on length of stay (P=0.484).Conclusion: Infants who received the n-3 fish oil-enriched IVLE have a lower mortality rate but there is no difference on length of stay.

Keywords: Infants, Intestinal surgery, Intravenous lipid emulsion, Length of stay, Mortality

Keywords


infants, intestinal surgery, intravenous lipid emulsion, length of stay, mortality

Full Text:

PDF

References


Puiggros C, Sanchez J, Chacon P, Sabin P, Rosello J, Bou R et al. Evolution of lipid profile, liver function, and pattern of plasma fatty acids according to the type of lipid emulsion administered in parenteral nutrition in the early postoperative period after digestive surgery. J Parenter Enteral Nutr. 2009; 33(5): 501-12.

The American Society for Parenteral and Enteral Nutrition (ASPEN). Guidelines for the Use of Parenteral and Enteral Nutrition in Adult and Pediatric Patients Section I : Introduction. J Parenter Enter Nutr. 2002;26:1–138.

Biesboer AN, Stoehr NA. A product review of alternative oil- based intravenous fat emulsions. Nutr Clin Pract. 2016;31:610–8.

Sungurtekin H, Degirmenci S, Sungurtekin U, Oguz BE, Sabir N, Kaptanoglu B. Comparison of the effects of different intravenous fat emulsions in patients with systemic inflammatory response syndrome and sepsis. Nutr Clin Pract. 2011; 26(6): 665-71.

Wanten GJ , Calder PC. Immune modulation by parenteral lipid emulsions. Am J Clin Nutr. 2007; 85(5): 1171-84.6.

Waitzberg DL, Torrinhas RS. Fish oil lipid emulsions and immune response: what clinicians need to know. Nutr Clin Pract. 2009; 24(4): 487-99.

Pradelli L, Mayer K, Muscaritoli M, Heller AR. n-3 fatty acid-enriched parenteral nutrition regimens in elective surgical and ICU patients: A meta-analysis. Crit Care. 2012; 16(5): 1-10.

Heller AR, Rossel T, Gottschlich B, Tiebel O, Menschikowski M, Litz RJ, et al. Omega-3 fatty acids improve liver and pancreas function in postoperative cancer patients. Int J Cancer. 2004; 10;111(4):611-6.

Calder PC. ω-3 polyunsaturated fatty acids, inflammation, and inflammatory diseases. American J Clin Nutr. 2006; 83(6): 1505-19.

Ma C, Sun L, Chen FM, Lu CY, Shih YL, Tsai HL et al. A double-blind randomized study comparing the efficacy and safety of a composite vs a conventional intravenous fat emulsion in postsurgical gastrointestinal tumor patients. Nutr Clin Pract. 2012; 27(3): 410-512.

Nusinovich Y, Revenis M, Torres C. Long-term outcomes for infants with intestinal atresia studied at Children's National Medical Center. J Pediatr Gastroenterol Nutr. 2013;57(3), 324-9.

Koletzko B, Goulet O, Hunt J, Krohn K, Shamir R. Guidelines on paediatric parenteral nutrition of the European Society of Paediatric Gastroenterology, Hepatology and Nutrition (ESPGHAN) and the European Society for Clinical Nutrition and Metabolism (ESPEN), Supported by the European Society of Paediatri. J Pediatr Gastroenterol Nutr. 2005;41:1–87.

Dorota W, Agnieszka S. Original/pediatríc evaluation of physical stability of all in one parenteral admixtures for pediatric home care with high electrolytes concentrations. Nutr Hosp. 2015; 31(1): 236-43.

Chang MI, Puder M, Gura KM. The use of fish oil lipid emulsion in the treatment of intestinal failure associated liver disease (IFALD). Nutrients. 2012;4:1828–50.

Jiang ZM, Wilmore DW, Wang XR, Wei JM, Zhang ZT, Gu ZY. Randomized clinical trial of intravenous soybean oil alone versus soybean oil plus fish oil outcome after major abdominal surgery. Br J Surg. 2010; 97(6): 804-9.

Li NN, Zhou Y, Qin XP, Chen Y, He D, Feng JY et al. Does intravenous fish oil benefit patients post-surgery? A meta-analysis of randomised controlled trials. Clin Nutr. 2014; 33(2): 226-39.

Wei C, Hua J, Bin C, Klassen K. Impact of lipid emulsion containing fish oil on outcomes of surgical patients: systematic review of randomized controlled trials from Europe and Asia. Nutrition. 2010; 26(5): 474-81.




DOI: https://doi.org/10.33846/hn.v3i3.314

Refbacks

  • There are currently no refbacks.


Copyright (c) 2019 Meta Herdiana Hanindita, Khadijah Rizky Sumitro, Nur Aisiyah Widjaja, Roedi Irawan, Boerhan Hidayat

"HEALTH NOTIONS" ISSN: 2580-4936 (online version only), published by Humanistic Network for Science and Technology    

Cemara street 25, 001/002, Dare, Ds./Kec. Sukorejo, Ponorogo, East Java, Indonesia, 63453
Phone/WhatsApp: +628133134413